CAS 71109-09-6: Vedaprofen

Vedaprofen CRS

Applications Propionic acid type non-steroidal anti-inflammatory drug (NSAID). References Mitchell, J., et al.: Biochem. Pharmacol., 50, 1535 (1995), Haak, T., et al.: Clin. Exp. Rheumatol., 14(6), 633 (1996), Lees, P., et al.: J. Vet. Pharmacol. Ther., 22, 96 (1999), Hawkey, C., et al.: Arthritis Rheum., 43, 370 (2000),

Vedaprofen is a nonsteroidal anti-inflammatory drug that belongs to the class of drugs known as NSAIDs. It inhibits the activity of the enzyme cyclooxygenase (COX), which causes inflammation and pain. Vedaprofen has been shown to be effective in treating bowel disease, inflammatory bowel disease, and autoimmune diseases, such as arthritis. Vedaprofen also has antimicrobial properties, inhibiting bacterial growth by binding to the COX enzyme in the cell membrane. The α subunit is one of the effector proteins for COX-1 and COX-2, and vedaprofen binds to this protein preventing its activation. This inhibitory effect on COX-1 and COX-2 leads to a reduction in production of prostaglandins (PGs) that are responsible for inflammatory responses. Vedaprofen may be administered orally or intravenously depending on the severity of symptoms. The oral route is preferred because it does not require

Vedaprofen (PM 150) is a COX-1 inhibitor with anti-inflammatory effects, blocking E. coli clamp at IC50 222 μM, Ki 131 μM.

Vedaprofen